John F. Thero - 04 Feb 2022 Form 3 Insider Report for Cyteir Therapeutics, Inc.

Role: Director
Signature: By: /s/ Andrew Gengos, Attorney-in-Fact
Issuer symbol: N/A
Transactions as of: 04 Feb 2022
Net transactions value: $0
Form type: 3
Filing time: 07 Feb 2022, 07:26:53 UTC
Previous filing: 06 Jan 2022
Next filing: 12 May 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney